Enforcement BriefingBack to stories →
← Back to stories
Billing fraud & false claimsNew in this edition

Tennessee pain clinic and managers agree to pay $1.5 million over allegedly unnecessary drug, allergy and psychological testing

The U.S. Attorney for the Middle District of Tennessee announced on November 12 that Clarksville Pain Institute, LLC, Pain Institute of Nashville, Michael Cox and Debbie Cox agreed to pay $1.5 million to resolve False Claims Act allegations. According to the United States' complaint, they submitted or caused false claims to Medicare and the Department of Veterans Affairs for medically unnecessary urine drug testing, allergy testing and psychological testing between April 2014 and May 2024. The whistleblower, a former employee, will receive $285,000. The release says the claims are allegations only and there has been no determination of liability.

Background

The settlement resolves a qui tam suit, United States ex rel. Nicholson v. Clarksville Pain Institute, Case No. 3:20-cv-00309 (M.D. Tenn.), in which the United States filed its own complaint on September 11, 2024. The clinic merged with Pain Institute of Nashville in 2018.

Who this affects

Pain management practices and hospital-owned clinics and laboratories that order or bill urine drug, allergy and psychological testing.

Why it matters

Inference: this release describes allegations of medically unnecessary urine drug, allergy and psychological testing at a pain practice, and a hospital-owned pain program or laboratory that orders or bills those tests could review whether its order sets and documentation show patient-specific medical necessity.

Scope and timing

Authority status
Settled
Responsible owner
Compliance; Laboratory; Revenue Cycle
Publication date
2026-11-12
Other dates
Alleged conduct April 2014 to May 2024; United States complaint filed September 11, 2024.

Not established

The settlement agreement was not retrieved; the release does not mention a Corporate Integrity Agreement.

Sources

Complete edition and supplemental material

This article in the complete report →

Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.

Read the entire Enforcement Briefing report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies